Physician profile
Mark J Goodwin
NPI 1639125867
$121,045.02
in general payments reported to CMS, 2019-2025
42 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $2,950 · 2021: $51K · 2022: $2,103 · 2023: $8,538 · 2024: $14K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Travel and Lodging: $3,158 · Honoraria: $750 · Entertainment: $612 · Education: $1.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,617.88 |
| Consulting Fee | $10,510.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Travel and Lodging | $3,158.36 |
| Honoraria | $750.00 |
| Entertainment | $612.19 |
| Education | $1.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $62,703.51 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Boston Scientific Corporation | $19,235.31 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Synergy |
| Cordis US Corp. | $15,886.30 | 2024-2025 | Selution Slr Pta, Cardio, S.M.A.R.T. |
| Philips North America LLC | $8,940.03 | 2019-2024 | (Cn3) Zenition 90, (Cq0) Azurion 5 M20 Gc |
| Asahi Intecc USA, INC. | $3,079.62 | 2019-2025 | Asahi Ptca Guide Wire, Peripheral Vascular, Asahi Coronary Wires |
| Abbott Laboratories | $2,146.63 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Diamondback Coronary |
| Medtronic, INC. | $1,947.70 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Siemens Medical Solutions USA, INC. | $1,291.27 | 2019 | |
| Opsens INC. | $907.49 | 2021-2023 | Optowire |
| Shockwave Medical, INC | $628.61 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $621.24 | 2024-2025 | Savvywire, Cardiva Vascade Mvp Xl Vvcs 10-12f, Optowire |
| Asahi Intecc Co., LTD. | $494.32 | 2020-2025 | |
| Abiomed | $447.58 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $323.18 | 2021-2025 | |
| Medtronic Vascular, INC. | $266.27 | 2019 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corindus INC. | $172.03 | 2019 | |
| Impulse Dynamics (USA) INC. | $158.67 | 2024 | Optimizer |
| W. L. Gore & Associates, INC. | $153.82 | 2022-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Shimadzu Precision Instruments, INC. | $150.00 | 2023 | Trinias |
| Cardiac Dimensions, INC. | $142.67 | 2024 | |
| Heartflow, INC. | $131.43 | 2019 | |
| Cvrx, INC. | $119.54 | 2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $90.65 | 2020-2025 | Camzyos, Eliquis |
| Amgen INC. | $87.81 | 2020-2023 | Repatha |
| Penumbra, INC. | $87.66 | 2023 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.63 | 2019-2024 | Jardiance |
| Surmodics, INC. | $84.10 | 2022-2023 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Teleflex LLC | $76.68 | 2025 | Turnpike |
| Pfizer INC. | $71.91 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $68.25 | 2021 | |
| Angiodynamics, INC. | $64.09 | 2024 | Smart Port Ct |
| Janssen Pharmaceuticals, INC | $55.11 | 2021-2023 | Xarelto |
| Merge Healthcare Incorporated | $49.89 | 2021 | |
| Alnylam Pharmaceuticals INC. | $45.37 | 2025 | Amvuttra |
| Lemaitre Vascular, INC. | $44.56 | 2023-2024 | Restoreflow |
| Astrazeneca Pharmaceuticals LP | $43.54 | 2022-2024 | Wainua |
| Scpharmaceuticals INC. | $36.01 | 2023 | |
| Merck Sharp & Dohme LLC | $35.27 | 2024-2025 | Verquvo |
| Cathworks, INC. | $19.41 | 2023 | Ffrangio |
| Adagio Medical, INC. | $18.26 | 2022 | |
| Venturemed Group, INC. | $16.65 | 2025 | Flex Vessel Prep System |
| Biotronik INC. | $14.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$12,027.82 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.